Please submit any general inquiries that are not specific to scientific or business development to the link on the left.

All inquiries related to Ariavax's proprietary adjuvant technology, current vaccine candidates, or the applicability of our technology towards a specific antigen, should be emailed to the link on the left. Please be sure to include the following; type of inquest, company, name, and relevent contact information.